referral hospital was conducted from 2013 to 2016. Demographics, transport and operative (OR) timing, Rutherford classification, preoperative imaging, level of occlusion, procedural information, and fasciotomy characteristics were reviewed. Outcome measures included length of stay (LOS), LS, discharge disposition, and mortality.
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Distal Bypass for Chronic Limb-Threatening Ischemia of the Upper Extremity
Objectives: Distal upper extremity vein bypass (dUEVB) is an infrequent procedure mainly performed for trauma, hemodialysis-associated pathologies, or chronic ischemia. There is little knowledge about the natural history of chronic ischemic disease of the upper extremity and only minimal knowledge about outcome of distal revascularization and limb salvage. Guidelines for the management of chronic ischemia of the upper extremity are missing. We have investigated the outcome of dUEVB for chronic ischemia.
Methods: This was a retrospective analysis of a consecutively collected case series in an academic tertiary referral setting. Standard statistical and reporting methods were used.
Results: A total of 209 bypass procedures in the upper extremity were collected from March 1996 to November 2016. Of these, 93 procedures in 78 patients (64 men [69.8%]) were performed for chronic ischemia and are the basis of this report. Median age was 55.5 (14.3-87.7) years. Vascular risk factors were nicotine use, 50 (53.8%); hypertension, 59 (64.5%); diabetes, 27 (29.0%); hyperlipidemia, 57 (61.3%); and renal failure, 23 (24.7%). Gangrene was present in 40 (43.0%). Underlying pathology: atherosclerotic, 42 (45.2%); chronic posttraumatic, 21 (22.6%); chronic postembolic, 13 (14.4%); thrombosed aneurysm/ hypothenar hammer, 8 (8.9%); Horton disease, 4 (4.4%); Buerger disease, 3 (3.3%); and Takayasu, 2 (2.2%). Distal target artery: brachial artery, 26 (27.9%); forearm arteries, 24 (25.8%); and distal to the wrist, 43 (46.2%). Vein grafts source: arm vein, 47 (50.5%); great saphenous, 37 (39.8%); and small saphenous, 9 (9.7%). Antithrombotic therapy:
antiaggregation, 49 (52.7%); anticoagulation, 13 (13.9%); and combination, 31 (33.3%). Five-year outcome: primary patency, 65%; limb salvage, 95%; and survival, 89%. Univariate analysis for adverse outcome: graft patency: female sex (P ¼ .001), diabetes (P ¼ .016), renal insufficiency (P ¼ .022); limb salvage: location of arterial occlusion (P ¼ .048); patient survival: diabetes (P ¼ .001), hypertension (P ¼ .029), and renal failure (P ¼ .0003). In multivariate analysis only renal failure was identified as an independent risk factor for inferior survival: hazard ratio, 8.28 (P ¼ .0023)
Conclusions: Indication for dUEVB for chronic ischemia is rare. Patients present with a wide variety of diseases for revascularization. Indication for surgery, graft choice, antithrombotic therapy, and outflow artery do not influence outcome. The only independent factor influencing survival is renal failure. dUEVB for chronic ischemia can be performed safely, and with excellent long-term results.
Author Disclosures: M. Aspalter: Nothing to disclose; J. Ellacuriaga San Martin: Nothing to disclose; F. Enzmann: Nothing to disclose; T. Hölzen-bein: Nothing to disclose; N. Hübl: Nothing to disclose; W. Hofmann: Nothing to disclose; K. Linni: Nothing to disclose; W. Hitzl: Nothing to disclose. Objectives: Unstable carotid stenosis is a major cause of stroke, but we lack methods to identify patients and lesions at risk. We recently described enrichment of molecular pathways associated with vascular calcification in carotid plaques from asymptomatic patients and from patients on statins. Here, we tested the hypothesis that calcification is a stabilizing feature in carotid atherosclerosis and examined whether calcification estimated by computed tomography (CT) can reflect plaque phenotype.
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Combination of Preoperative CT and Carotid
Methods: Carotid endarterectomies from patients with symptomatic (S) and asymptomatic (AS) carotid stenosis were part of the Biobank of Karolinska Endarterectomies (BiKE). The calcification ratio was measured in preoperative CT angiographies using the plaque analysis application from the iNtuition software (TeraRecon), with threshold set to >400 HU. We used a discovery cohort with 19 high-calcified (18%-65%) and 21 low-calcified plaques (0%-9%) and a validation cohort of 127 plaques (87 S and 40 AS) and 10 normal arteries (NA). Plaques were profiled using Affymetrix microarrays and gene set enrichment and pathway mapping on differentially expressed genes. Results were adjusted for age, gender, and symptoms, corrected for multiple comparisons, and significance 
